CD44 standard form expression is correlated with high-grade and advanced-stage ovarian carcinoma but not prognosis

J Zhang, B Chang, J Liu - Human pathology, 2013 - Elsevier
Single-chain glycoprotein CD44 is a major cell surface receptor for hyaluronan and
mediates epithelial cell adhesion by its involvement in cell-cell and cell-matrix interactions …

CD44 expression indicates favorable prognosis in epithelial ovarian cancer

S Sillanpää, MA Anttila, K Voutilainen… - Clinical Cancer …, 2003 - AACR
Purpose: The purpose of this study was to investigate the expression and prognostic
significance of CD44 in epithelial ovarian cancer. Experimental Design: We analyzed the …

CD44 expression in benign, premalignant, and malignant ovarian neoplasms: relation to tumour development and progression

M Saegusa, D Machida, M Hashimura… - The Journal of …, 1999 - Wiley Online Library
To clarify the possible role of CD44 expression in ovarian tumour development and
progression, an immunohistochemical investigation was undertaken of a series of 115 …

CD44 variant expression is a common feature of epithelial ovarian cancer: lack of association with standard prognostic factors.

SA Cannistra, G Abu-Jawdeh, J Niloff… - Journal of clinical …, 1995 - ascopubs.org
PURPOSE CD44 is a hyaluronic acid receptor that exists as a standard 90-kd form (CD44S)
as well as several CD44 variant isoforms produced through alternative splicing. Expression …

Decreased CD44 standard form expression correlates with prognostic variables in ovarian carcinomas

JS Ross, CE Sheehan, SS Williams… - American journal of …, 2001 - academic.oup.com
Expression of CD44 standard form (CD44s) was evaluated by automated
immunohistochemical analysis using the anti-CD44 A3D8 clone in 101 ovarian epithelial …

Expression and function of CD44 in epithelial ovarian carcinoma

JD Sacks, MV Barbolina - Biomolecules, 2015 - mdpi.com
CD44, a cell surface glycoprotein, has been increasingly implicated in the pathogenesis and
progression of epithelial ovarian cancer, the deadliest gynecologic malignancy in women …

The prognostic role of the cancer stem cell marker CD44 in ovarian cancer: a meta-analysis

J Lin, D Ding - Cancer cell international, 2017 - Springer
Background CD44 has recently been reported as a cancer stem cell marker in ovarian
cancer. However, the clinicopathological and prognostic value of this marker in ovarian …

Expression of CD44v6 and its association with prognosis in epithelial ovarian carcinomas

D Zhou, Y Liu, Y Xue - Pathology Research International, 2012 - Wiley Online Library
The aim of this study was to evaluate CD44v6 protein expression and its prognostic value of
CD44v6 in ovarian carcinoma. The expression of CD44v6 was analyzed in 62 patients with …

CD44 splice variant v8-10 as a marker of serous ovarian cancer prognosis

A Sosulski, H Horn, L Zhang, C Coletti… - PloS one, 2016 - journals.plos.org
CD44 is a transmembrane hyaluronic acid receptor gene that encodes over 100 different
tissue-specific protein isoforms. The most ubiquitous, CD44 standard, has been used as a …

CD44 Immunoexpression is unfavorable predictor in ovarian serous cancer

DK Križanac, AK Arapović, S Skočibušić… - Applied …, 2018 - journals.lww.com
The aim of this study was to clarify the clinical role of CD44 expression in ovarian serous
cancer, and its relation to clinicopathologic prognostic factors, disease free survival and …